← Back to Search

Mesh Implant

Phasix™ Mesh for Open Laparotomy Recovery (PREVENT Trial)

N/A
Recruiting
Led By William Hope, MD
Research Sponsored by C. R. Bard
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Elective, open midline laparotomy ≥ 5 cm
Must be ≥ 18 years of age
Must not have
The surgery requires more than a single piece of mesh
Two separate incisions are created
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60-months
Awards & highlights

Summary

This trial is to see if the Phasix Mesh implant prevents incisional hernias better than just using regular stitches.

Who is the study for?
This trial is for adults who need elective open laparotomy surgery, have a moderate or higher risk of hernia, and can consent to the study. It's not for those with prior mesh implants, contraindications to mesh placement, previous hernia repairs, skin issues at the site, life expectancy under 3 years, pregnancy plans during the trial period, certain steroid use before surgery or known allergies to specific antibiotics.
What is being tested?
The study tests if implanting Phasix™ Mesh during midline fascial closure in abdominal surgery is better than just suturing for preventing future incisional hernias in patients with a high risk of this complication.
What are the potential side effects?
Potential side effects may include discomfort at the implant site, infection risks associated with surgical mesh implants and possible allergic reactions to materials within Phasix™ Mesh.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a major abdominal surgery through a cut of at least 5 cm.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My surgery needs more than one piece of mesh.
Select...
I have had surgery with two separate cuts.
Select...
I have had surgery to fix a hernia before.
Select...
I have a current skin condition.
Select...
I do not have an active severe infection.
Select...
I am allergic to tetracycline or kanamycin.
Select...
I am scheduled for a second surgery.
Select...
My surgeon could not completely close the inner layer of my abdomen.
Select...
I need surgery urgently.
Select...
My surgery will involve creating skin flaps.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incisional hernia
Secondary outcome measures
Length of hospital stay in days
Length of surgical procedure in minutes
Length of time for wound closure in minutes
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Phasix™ MeshExperimental Treatment1 Intervention
Prophylactic onlay placement of mesh.
Group II: Primary Suture ClosureActive Control1 Intervention
Standard Fascial closure.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Phasix™ Mesh
2016
N/A
~90

Find a Location

Who is running the clinical trial?

C. R. BardLead Sponsor
103 Previous Clinical Trials
39,123 Total Patients Enrolled
William Hope, MDPrincipal InvestigatorNew Hanover Regional Medical Center
1 Previous Clinical Trials
120 Total Patients Enrolled

Media Library

Phasix™ Mesh (Mesh Implant) Clinical Trial Eligibility Overview. Trial Name: NCT03911700 — N/A
Open Laparotomy Research Study Groups: Primary Suture Closure, Phasix™ Mesh
Open Laparotomy Clinical Trial 2023: Phasix™ Mesh Highlights & Side Effects. Trial Name: NCT03911700 — N/A
Phasix™ Mesh (Mesh Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03911700 — N/A
Open Laparotomy Patient Testimony for trial: Trial Name: NCT03911700 — N/A
~243 spots leftby Sep 2029